senate Bill S8255

2019-2020 Legislative Session

Relates to capping cost sharing for insulin

download bill text pdf

Sponsored By

Current Bill Status - Passed Senate


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (6)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jul 22, 2020 referred to insurance
delivered to assembly
passed senate
ordered to third reading cal.990
Jul 20, 2020 reported and committed to rules
Apr 29, 2020 referred to insurance

Votes

view votes

Jul 22, 2020 - Rules committee Vote

S8255
17
2
committee
17
Aye
2
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Rules committee vote details

Jul 20, 2020 - Insurance committee Vote

S8255
7
0
committee
7
Aye
0
Nay
4
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Insurance committee vote details

Insurance Committee Vote: Jul 20, 2020

Co-Sponsors

view additional co-sponsors

S8255 (ACTIVE) - Details

See Assembly Version of this Bill:
A10821
Current Committee:
Assembly Insurance
Law Section:
Insurance Law
Laws Affected:
Amd §§3216, 3221 & 4303, Ins L

S8255 (ACTIVE) - Summary

Lowers the cost sharing cap for insulin from one hundred dollars to thirty dollars.

S8255 (ACTIVE) - Sponsor Memo

S8255 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  8255

                            I N  S E N A T E

                             April 29, 2020
                               ___________

Introduced  by Sens. RIVERA, HOYLMAN, KAMINSKY, KRUEGER, SALAZAR -- read
  twice and ordered printed, and when printed to  be  committed  to  the
  Committee on Insurance

AN  ACT  to amend the insurance law, in relation to capping cost sharing
  for insulin

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  Subparagraph  (B)  of paragraph 15-a of subsection (i) of
section 3216 of the insurance law, as amended by section 1 of  part  DDD
of chapter 56 of the laws of 2020, is amended to read as follows:
  (B) Such coverage may be subject to annual deductibles and coinsurance
as may be deemed appropriate by the superintendent and as are consistent
with  those  established  for  other  benefits  within  a  given policy;
provided however, the total amount that a covered person is required  to
pay out of pocket for covered prescription insulin drugs shall be capped
at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
supply, regardless of the amount or type of insulin needed to fill  such
covered  person's  prescription  and regardless of the insured's deduct-
ible, copayment, coinsurance or any other cost sharing requirement.
  § 2. Subparagraph (B) of paragraph 7 of subsection (k) of section 3221
of the insurance law, as amended by section 2 of part DDD of chapter  56
of the laws of 2020, is amended to read as follows:
  (B) Such coverage may be subject to annual deductibles and coinsurance
as may be deemed appropriate by the superintendent and as are consistent
with  those  established  for  other  benefits  within  a  given policy;
provided however, the total amount that a covered person is required  to
pay out of pocket for covered prescription insulin drugs shall be capped
at  an  amount not to exceed [one hundred] THIRTY dollars per thirty-day
supply, regardless of the amount or type of insulin needed to fill  such
covered  person's  prescription  and regardless of the insured's deduct-
ible, copayment, coinsurance or any other cost sharing requirement.
  § 3. Paragraph 2 of subsection (u) of section 4303  of  the  insurance
law,  as  amended  by section 3 of part DDD of chapter 56 of the laws of
2020, is amended to read as follows:

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.